$ONXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ONYX PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ONYX PHARMACEUTICALS INC. Get notifications about new insider transactions in ONYX PHARMACEUTICALS INC for free.
Page: < prev 1 ... 8 9 10 11 12
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 43.82 | 200 | 8,764 | 93,685 | 93.9 K to 93.7 K (-0.21 %) |
| Apr 05 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 43.81 | 400 | 17,524 | 93,885 | 94.3 K to 93.9 K (-0.42 %) |
| Apr 05 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 43.80 | 400 | 17,520 | 94,285 | 94.7 K to 94.3 K (-0.42 %) |
| Apr 05 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 43.79 | 300 | 13,137 | 94,685 | 95 K to 94.7 K (-0.32 %) |
| Apr 05 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 43.77 | 300 | 13,131 | 94,985 | 95.3 K to 95 K (-0.31 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.18 | 300 | 12,354 | 95,285 | 95.6 K to 95.3 K (-0.31 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.17 | 100 | 4,117 | 95,585 | 95.7 K to 95.6 K (-0.10 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.16 | 700 | 28,812 | 95,685 | 96.4 K to 95.7 K (-0.73 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.09 | 122 | 5,013 | 96,385 | 96.5 K to 96.4 K (-0.13 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.07 | 345 | 14,169 | 96,507 | 96.9 K to 96.5 K (-0.36 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.06 | 100 | 4,106 | 96,852 | 97 K to 96.9 K (-0.10 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.05 | 100 | 4,105 | 96,952 | 97.1 K to 97 K (-0.10 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 41.04 | 733 | 30,082 | 97,052 | 97.8 K to 97.1 K (-0.75 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | JEW JEANNE Y | VP, Corporate & Com ... | Option Exercise | M | 5.00 | 1,000 | 5,000 | 14,000 | |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | JEW JEANNE Y | VP, Corporate & Com ... | Option Exercise | M | 6.46 | 1,200 | 7,752 | 83,800 | |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | JEW JEANNE Y | VP, Corporate & Com ... | Sell | S | 39.96 | 2,200 | 87,912 | 0 | 2.2 K to 0 (-100.00 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | JEW JEANNE Y | VP, Corporate & Com ... | Buy | M | 5.00 | 1,000 | 5,000 | 2,200 | 1.2 K to 2.2 K (+83.33 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | JEW JEANNE Y | VP, Corporate & Com ... | Buy | M | 6.46 | 1,200 | 7,752 | 1,200 | 0 to 1.2 K |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Option Exercise | M | 10.00 | 10,000 | 100,000 | 160,000 | |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.40 | 2,900 | 114,260 | 14,729 | 17.6 K to 14.7 K (-16.45 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.44 | 100 | 3,944 | 17,629 | 17.7 K to 17.6 K (-0.56 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.45 | 100 | 3,945 | 17,729 | 17.8 K to 17.7 K (-0.56 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.46 | 100 | 3,946 | 17,829 | 17.9 K to 17.8 K (-0.56 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.48 | 100 | 3,948 | 17,929 | 18 K to 17.9 K (-0.55 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.50 | 2,200 | 86,900 | 18,029 | 20.2 K to 18 K (-10.88 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.51 | 400 | 15,804 | 20,229 | 20.6 K to 20.2 K (-1.94 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.53 | 100 | 3,953 | 20,629 | 20.7 K to 20.6 K (-0.48 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.54 | 200 | 7,908 | 20,729 | 20.9 K to 20.7 K (-0.96 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.55 | 200 | 7,910 | 20,929 | 21.1 K to 20.9 K (-0.95 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.56 | 100 | 3,956 | 21,129 | 21.2 K to 21.1 K (-0.47 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.57 | 500 | 19,785 | 21,229 | 21.7 K to 21.2 K (-2.30 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 39.60 | 3,000 | 118,800 | 21,729 | 24.7 K to 21.7 K (-12.13 %) |
| Mar 29 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Buy | M | 10.00 | 10,000 | 100,000 | 24,729 | 14.7 K to 24.7 K (+67.89 %) |
| Mar 26 2004 | ONXX | ONYX PHARMACEUTICA ... | WORTZMAN MARILYN E | VP, Finance and Adm ... | Option Exercise | M | 5.00 | 1,393 | 6,965 | 23,607 | |
| Mar 26 2004 | ONXX | ONYX PHARMACEUTICA ... | WORTZMAN MARILYN E | VP, Finance and Adm ... | Option Exercise | M | 4.00 | 1,250 | 5,000 | 9,062 | |
| Mar 26 2004 | ONXX | ONYX PHARMACEUTICA ... | WORTZMAN MARILYN E | VP, Finance and Adm ... | Sell | S | 37.50 | 2,643 | 99,113 | 486 | 3.1 K to 486 (-84.47 %) |
| Mar 26 2004 | ONXX | ONYX PHARMACEUTICA ... | WORTZMAN MARILYN E | VP, Finance and Adm ... | Buy | M | 5.00 | 1,393 | 6,965 | 3,129 | 1.7 K to 3.1 K (+80.24 %) |
| Mar 26 2004 | ONXX | ONYX PHARMACEUTICA ... | WORTZMAN MARILYN E | VP, Finance and Adm ... | Buy | M | 4.00 | 1,250 | 5,000 | 1,736 | 486 to 1.7 K (+257.20 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Option Exercise | M | 7.75 | 3,000 | 23,250 | 2,000 | |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Sell | S | 36.47 | 1,189 | 43,363 | 0 | 1.2 K to 0 (-100.00 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Sell | S | 36.49 | 399 | 14,560 | 1,189 | 1.6 K to 1.2 K (-25.13 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Sell | S | 36.50 | 100 | 3,650 | 1,588 | 1.7 K to 1.6 K (-5.92 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Sell | S | 36.52 | 194 | 7,085 | 1,688 | 1.9 K to 1.7 K (-10.31 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Sell | S | 36.59 | 425 | 15,551 | 1,882 | 2.3 K to 1.9 K (-18.42 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Sell | S | 36.64 | 693 | 25,392 | 2,307 | 3 K to 2.3 K (-23.10 %) |
| Mar 24 2004 | ONXX | ONYX PHARMACEUTICA ... | WIERENGA WENDALL D | Director | Buy | M | 7.75 | 3,000 | 23,250 | 3,000 | 0 to 3 K |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Option Exercise | M | 10.00 | 10,000 | 100,000 | 170,000 | |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 36.04 | 4,000 | 144,160 | 14,729 | 18.7 K to 14.7 K (-21.36 %) |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 36.03 | 400 | 14,412 | 18,729 | 19.1 K to 18.7 K (-2.09 %) |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 36.02 | 400 | 14,408 | 19,129 | 19.5 K to 19.1 K (-2.05 %) |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 36.01 | 2,800 | 100,828 | 19,529 | 22.3 K to 19.5 K (-12.54 %) |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Sell | S | 36.00 | 2,400 | 86,400 | 22,329 | 24.7 K to 22.3 K (-9.71 %) |
| Mar 23 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Buy | M | 10.00 | 10,000 | 100,000 | 24,729 | 14.7 K to 24.7 K (+67.89 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Option Exercise | D | 5.00 | 125 | 625 | 21,875 | |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Option Exercise | D | 4.00 | 2,604 | 10,416 | 14,583 | |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Option Exercise | D | 4.87 | 2,084 | 10,149 | 8,333 | |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Sell | S | 36.03 | 400 | 14,412 | 0 | 400 to 0 (-100.00 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Sell | S | 36.02 | 300 | 10,806 | 400 | 700 to 400 (-42.86 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Sell | S | 36.01 | 700 | 25,207 | 700 | 1.4 K to 700 (-50.00 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Sell | S | 36.00 | 3,413 | 122,868 | 1,400 | 4.8 K to 1.4 K (-70.91 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Buy | M | 5.00 | 125 | 625 | 4,813 | 4.7 K to 4.8 K (+2.67 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Buy | M | 4.00 | 2,604 | 10,416 | 4,688 | 2.1 K to 4.7 K (+124.95 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Buy | M | 4.87 | 2,084 | 10,149 | 2,084 | 0 to 2.1 K |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.71 | 1,000 | 35,710 | 97,785 | 98.8 K to 97.8 K (-1.01 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.70 | 243 | 8,675 | 98,785 | 99 K to 98.8 K (-0.25 %) |
| Mar 22 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.69 | 1,257 | 44,862 | 99,028 | 100.3 K to 99 K (-1.25 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.84 | 500 | 17,920 | 100,285 | 100.8 K to 100.3 K (-0.50 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.89 | 200 | 7,178 | 100,785 | 101 K to 100.8 K (-0.20 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.92 | 100 | 3,592 | 100,985 | 101.1 K to 101 K (-0.10 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.94 | 200 | 7,188 | 101,085 | 101.3 K to 101.1 K (-0.20 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 35.97 | 700 | 25,179 | 101,285 | 102 K to 101.3 K (-0.69 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.00 | 500 | 18,000 | 101,985 | 102.5 K to 102 K (-0.49 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.01 | 100 | 3,601 | 102,485 | 102.6 K to 102.5 K (-0.10 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.04 | 100 | 3,604 | 102,585 | 102.7 K to 102.6 K (-0.10 %) |
| Mar 15 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.12 | 100 | 3,612 | 102,685 | 102.8 K to 102.7 K (-0.10 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.53 | 200 | 7,506 | 102,785 | 103 K to 102.8 K (-0.19 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.54 | 789 | 29,619 | 102,985 | 103.8 K to 103 K (-0.76 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.61 | 200 | 7,522 | 103,774 | 104 K to 103.8 K (-0.19 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.66 | 300 | 11,298 | 103,974 | 104.3 K to 104 K (-0.29 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.63 | 111 | 4,177 | 104,274 | 104.4 K to 104.3 K (-0.11 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.64 | 600 | 22,584 | 104,385 | 105 K to 104.4 K (-0.57 %) |
| Mar 08 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 37.65 | 300 | 11,295 | 104,985 | 105.3 K to 105 K (-0.28 %) |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | FREEMAN SCOTT M | VP, Clinical Resear ... | Option Exercise | A | 38.08 | 40,000 | 1,523,200 | 40,000 | |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | WOOD JULIANNA R | VP, Corp. Communica ... | Option Exercise | A | 38.08 | 15,000 | 571,200 | 15,000 | |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | WORTZMAN MARILYN E | VP, Finance and Adm ... | Option Exercise | A | 38.08 | 30,000 | 1,142,400 | 30,000 | |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | POST LEONARD E | SVP, Research & Dev ... | Option Exercise | A | 38.08 | 50,000 | 1,904,000 | 50,000 | |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | JEW JEANNE Y | VP, Corporate & Com ... | Option Exercise | A | 38.08 | 25,000 | 952,000 | 25,000 | |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Option Exercise | A | 38.08 | 100,000 | 3,808,000 | 100,000 | |
| Mar 04 2004 | ONXX | ONYX PHARMACEUTICA ... | GIOTTA GREGORY J | VP & Chief Legal Co ... | Option Exercise | A | 38.08 | 25,000 | 952,000 | 25,000 | |
| Mar 01 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.49 | 500 | 18,245 | 99,889 | 100.4 K to 99.9 K (-0.50 %) |
| Mar 01 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.47 | 600 | 21,882 | 100,389 | 101 K to 100.4 K (-0.59 %) |
| Mar 01 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.48 | 100 | 3,648 | 100,989 | 101.1 K to 101 K (-0.10 %) |
| Mar 01 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.48 | 300 | 10,944 | 101,089 | 101.4 K to 101.1 K (-0.30 %) |
| Mar 01 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 36.64 | 1,000 | 36,640 | 101,389 | 102.4 K to 101.4 K (-0.98 %) |
| Feb 23 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 34.68 | 2,500 | 86,711 | 102,389 | 104.9 K to 102.4 K (-2.38 %) |
| Feb 17 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.78 | 565 | 19,086 | 104,889 | 105.5 K to 104.9 K (-0.54 %) |
| Feb 17 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.80 | 200 | 6,760 | 105,454 | 105.7 K to 105.5 K (-0.19 %) |
| Feb 17 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.81 | 200 | 6,762 | 105,654 | 105.9 K to 105.7 K (-0.19 %) |
| Feb 17 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.90 | 100 | 3,390 | 105,854 | 106 K to 105.9 K (-0.09 %) |
| Feb 17 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.93 | 1,100 | 37,323 | 105,954 | 107.1 K to 106 K (-1.03 %) |
| Feb 17 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.95 | 335 | 11,373 | 107,054 | 107.4 K to 107.1 K (-0.31 %) |
| Feb 09 2004 | ONXX | ONYX PHARMACEUTICA ... | GODDARD PAUL | Director | Option Exercise | A | 33.56 | 5,000 | 167,800 | 5,000 | |
| Feb 09 2004 | ONXX | ONYX PHARMACEUTICA ... | VITULLO NICOLE | Director | Option Exercise | A | 33.75 | 5,000 | 168,750 | 5,000 | |
| Feb 02 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 34.01 | 100 | 3,401 | 109,889 | 110 K to 109.9 K (-0.09 %) |
| Feb 02 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.97 | 100 | 3,397 | 109,989 | 110.1 K to 110 K (-0.09 %) |
| Feb 02 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.94 | 300 | 10,182 | 110,089 | 110.4 K to 110.1 K (-0.27 %) |
| Feb 02 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.81 | 1,000 | 33,810 | 110,389 | 111.4 K to 110.4 K (-0.90 %) |
| Feb 02 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.77 | 1,000 | 33,770 | 111,389 | 112.4 K to 111.4 K (-0.89 %) |
| Feb 09 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.63 | 1,000 | 33,630 | 107,389 | 108.4 K to 107.4 K (-0.92 %) |
| Feb 09 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.53 | 300 | 10,059 | 108,389 | 108.7 K to 108.4 K (-0.28 %) |
| Feb 09 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.54 | 600 | 20,125 | 108,689 | 109.3 K to 108.7 K (-0.55 %) |
| Feb 09 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.54 | 600 | 20,124 | 109,289 | 109.9 K to 109.3 K (-0.55 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.25 | 1,000 | 33,250 | 112,389 | 113.4 K to 112.4 K (-0.88 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.10 | 100 | 3,310 | 113,389 | 113.5 K to 113.4 K (-0.09 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 33.09 | 200 | 6,618 | 113,489 | 113.7 K to 113.5 K (-0.18 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 32.99 | 500 | 16,495 | 113,689 | 114.2 K to 113.7 K (-0.44 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 32.98 | 100 | 3,298 | 114,189 | 114.3 K to 114.2 K (-0.09 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 32.89 | 200 | 6,578 | 114,289 | 114.5 K to 114.3 K (-0.17 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 32.85 | 100 | 3,285 | 114,489 | 114.6 K to 114.5 K (-0.09 %) |
| Jan 26 2004 | ONXX | ONYX PHARMACEUTICA ... | RENTON HOLLINGS | President and CEO | Sell | S | 32.87 | 300 | 9,861 | 114,589 | 114.9 K to 114.6 K (-0.26 %) |